Morgan Stanley Cumberland Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 12,398 shares of CPIX stock, worth $36,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,398

Previous 2,660 366.09%

Holding current value

$36,078

Previous $11,000 272.73%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$2.55 - $5.89 $24,831 - $57,356	9,738 Added 366.09%	12,398 $41,000
Q2 2024 Oct 17, 2024	SELL	$1.39 - $1.78 $11,973 - $15,332	-8,614 Reduced 76.41%	2,660 $4,000
Q2 2024 Aug 14, 2024	SELL	$1.39 - $1.78 $11,973 - $15,332	-8,614 Reduced 76.41%	2,660 $4,000
Q1 2024 Oct 17, 2024	BUY	$1.68 - $2.24 $14,471 - $19,295	8,614 Added 323.83%	11,274 $18,000
Q4 2023 Aug 16, 2024	BUY	$1.6 - $2.14 $13,782 - $18,433	8,614 Added 323.83%	11,274 $20,000
Q1 2023 May 15, 2023	SELL	$1.92 - $2.75 $1 - $2	-1 Reduced 0.01%	11,274 $21,000
Q4 2022 Feb 14, 2023	SELL	$2.11 - $2.6 $3,416 - $4,209	-1,619 Reduced 12.56%	11,275 $25,000
Q3 2022 Nov 14, 2022	BUY	$2.06 - $2.63 $21,082 - $26,915	10,234 Added 384.74%	12,894 $31,000
Q2 2022 Oct 27, 2022	SELL	$1.93 - $3.03 $955 - $1,499	-495 Reduced 15.69%	2,660 $6,000
Q2 2022 Aug 15, 2022	SELL	$1.93 - $3.03 $955 - $1,499	-495 Reduced 15.69%	2,660 $6,000
Q1 2022 Oct 27, 2022	BUY	$2.56 - $4.98 $1,267 - $2,465	495 Added 18.61%	3,155 $9,000
Q1 2022 May 13, 2022	BUY	$2.56 - $4.98 $1,239 - $2,410	484 Added 18.12%	3,155 $9,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $6.94 $1,102 - $3,476	-501 Reduced 15.79%	2,671 $12,000
Q3 2021 Nov 15, 2021	BUY	$2.66 - $3.45 $8,437 - $10,943	3,172 New	3,172 $8,000

Others Institutions Holding CPIX

# of Institutions

Shares Held

3.67M

Call Options Held

65.9K

Put Options Held

View Full List

About CUMBERLAND PHARMACEUTICALS INC

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $42.7M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

More about CPIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account